Article Text

Download PDFPDF

P241 Detection of Y-chromosomal DNA correlates with last unsafe sexual exposure
  1. Petra Wolffs1,
  2. Christian Hoebe2,
  3. Jos Herbergs3,
  4. Mayk Lucchesi1,
  5. Sylvia Bruisten4,
  6. Hannelore Götz5,
  7. Mark Van Berkel3,
  8. Henry De Vries6,
  9. Nicole Dukers-Muijrers7
  1. 1Maastricht University Medical Center (MUMC), Medical Microbiology, Care and Public Health Research Institute (CAPHRI), Maastricht, Netherlands
  2. 2Public Health Service South Limburg, Maastricht University Medical Center (MUMC), Sexual Health, Infectious Diseases and Environmental Health, Medical Microbiology, Care and Public Health Research Institute (CAPHRI), Heerlen, Netherlands
  3. 3The Maastricht Forensic Institute, Maastricht, Netherlands
  4. 4Public Health Service Amsterdam, Amsterdam University Medical Center (UMC), Infectious Diseases, Infection and Immunity (AI and II), Amsterdam, Netherlands
  5. 51 Public Health Service Rotterdam Rijnmond; 2 Erasmus MC University Medical Center Rotterdam; 3 National Institute for Public Health and the Environment (RIVM), 1 Public Health/Sexual Health; 2 Department of Public Health; 3 Epidemiology and Surveillance Unit, Centre for Infectious Disease Control, Rotterdam, Netherlands
  6. 6Public Health Service Amsterdam, Amsterdam University Medical Center (UMC), National Institute of Public Health and the Environment (RIVM), Infectious Diseases Infection and Immunity Institute (AI and II), Epidemiology and Surveillance Unit, Amsterdam, Netherlands
  7. 7Public Health Service South Limburg, Sexual Health, Infectious Diseases and Environmental Health, Heerlen, Netherlands


Background When Chlamydia trachomatis (CT) is detected after adequate treatment, this may reflect treatment failure or re-infection due to sexual re-exposure. For sexual exposure, researchers rely on self-reported data. Biomarkers such as Y-chromosomal DNA (Y-DNA) from vaginal and rectal samples may be used to support the validity of the self-reported sexual exposure data. The aim of this study was to validate detection of Y-DNA in a cohort of treated female CT patients, the Femcure study.

Methods Participants provided self-swabs for various days after treatment. For each swab, self-reported last unsafe (vaginal or rectal) sexual exposure (LUSE) was recorded in days (range t0-t14). Samples consisted of vaginal (n=120: 20 swabs at t=0,1,2,3,4; and 20 swabs at t=7,8) and rectal (n=43, 6 swabs at t0–1; 15 swabs at t2–5 and 22 swabs at t6–14) CT negative swabs in Roche COBAS PCR uniswab media (FemCure 2016–2017). CT negative human semen was used for spiking experiments. Quantitative detection of Y-DNA was performed using Quantifiler® Duo DNA Quantification Kit.

Results Samples with realistic spiked concentrations of ∼0.5 ng/microliter Y-DNA remained stable and detectable until at least 35 days in the medium at 4°C. For vaginal swabs, detection of Y-DNA correlated inversely with LUSE: the Y-DNA detection percentage was 90%, 60%, 30%,10%, 20% at t=0,1,2,3,4, and 5% at t7,8. In anal swabs, detection was 33% at t0–1 and 13% at t2–5 and t6–14.

Conclusion Y-DNA correlates strongly with LUSE in vaginal swabs, with high Y-DNA detection in the first 48 hours. Y-DNA detection data can be used to support self-reported sexual exposure data used in most research. The detection of Y-DNA in anal swabs has to be further validated as our study only included a limited number of anal samples at early time-points.

Disclosure No significant relationships.

  • miscellaneous clinical

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.